Michael Burry
Michael Burry's Scion Asset Management holds 8 U.S.-equity positions worth $1.4B (SEC 13F, Q3 2025). Top positions: Palantir Technologies Inc. Class A Common Stock 66.0%, NVIDIA CORP 13.5%, Pfizer Inc. 11.1%. 13F-replication return is +66% over 3 years (-6 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| PLTR Palantir Technologies Inc. Class A Common Stock | 66.0% | 5.0M | $912M | NEW (+5.0M) | $182.42 | $119.50 (−34%) | 2025-09-30 |
| NVDA NVIDIA CORP | 13.5% | 1.0M | $187M | NEW (+1.0M) | $108.38 | $208.65 (+93%) | 2025-09-30 |
| PFE Pfizer Inc. | 11.1% | 6.0M | $153M | NEW (+6.0M) | $25.48 | $25.08 (−2%) | 2025-09-30 |
| HAL Halliburton Company | 4.5% | 2.5M | $62M | NEW (+2.5M) | $24.60 | $35.17 (+43%) | 2025-09-30 |
| MOH Molina Healthcare, Inc. | 1.7% | 125K | $24M | NEW (+125K) | $297.30 | $197.42 (−34%) | 2025-09-30 |
| LULU lululemon athletica inc. | 1.3% | 100K | $18M | ▼ 78% (−350K) | $237.58 | $105.43 (−56%) | 2025-09-30 |
| SLM SLM Corporation | 1.0% | 480K | $13M | NEW (+480K) | $27.68 | $22.84 (−17%) | 2025-09-30 |
| BRKRP Bruker Corp | 0.9% | 48K | $13M | NEW (+48K) | $271.80 | $421.22 (+55%) | 2025-09-30 |
FAQ ▾
What are Michael Burry's largest holdings?
As of the latest 13F: Palantir Technologies Inc. Class A Common Stock 66.0%, NVIDIA CORP 13.5%, Pfizer Inc. 11.1%, Halliburton Company 4.5%, Molina Healthcare, Inc. 1.7%.
How big is Scion Asset Management's 13F portfolio?
$1.4B across 8 disclosed U.S.-equity positions.
What is Michael Burry's 3-year performance?
+66% (13F-replication, price return), -6 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.